ENFERMEDAD DE TAKAYASU PEDIATRIA PDF

PDF | Takayasu arteritis is an idiopathic granulomatous vasculitis of the Service of Immunology & Rheumatology, Hospital de Pediatría “Prof. Resumen. Introducción: La arteritis de Takayasu es una vasculitis sistémica, de etiología autoinmune, que afecta principalmente a grandes. Palabras clave: Vasculitis Sistémicas, clasificación, Pediatría Katsicas MM, Pompozi L, Russo R. Arteritis de Takayasu en pediatría.

Author: Nasho Gardatilar
Country: Ukraine
Language: English (Spanish)
Genre: Science
Published (Last): 10 October 2007
Pages: 418
PDF File Size: 15.59 Mb
ePub File Size: 10.50 Mb
ISBN: 520-7-81375-775-1
Downloads: 41000
Price: Free* [*Free Regsitration Required]
Uploader: Tojanos

The clinical characteristics of Chinese Takayasu’s arteritis patients: After remission is achieved, treatment needs takayzsu be continued in the majority of patients to diminish risk of flares and disease progression.

Both MRA and CTA provide cross-sectional arterial wall images and allow detection of intramural inflammation, and they both demonstrate high specificity and sensitivity for the diagnosis and disease activity assessment — Schematic figure showing possible mechanisms in the aortic wall. Inflammation and intimal proliferation lead to wall thickening, stenotic or occlusive lesions, and thrombosis, while destruction of the elastica and muscularis layers originates aneurysms and dissection.

Pathogenesis of Takayasu’s arteritis. Antigenic targets and pathogenicity of antiaortic endothelial cell antibodies in Takayasu arteritis. To make an early diagnosis, pediatricians should be aware of inflammatory systemic manifestations and cardiovascular abnormalities.

  EL ARTE DE ENVEJECER AMANDO DE MIGUEL PDF

Management Treatment of TA is aimed at controlling vascular inflammation and preventing irreversible organ damage. Open in re separate window. Is 18 F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Curr Opin Rheumatol ; Other investigators, however, have found this method to be not as sensitive and specific for disease activity Incidence of Aneurysm in Takayasu’s Arteritis.

Heart Vessels 7 Suppl. J Peduatria Nefrol, 28pp. Controversias en el enfermwdad de la trombocitopenia Classic IS and biologic agents in the last decade have been used in the induction pediatris maintenance therapy of adult and pediatric patients with TA, but except for a few controlled clinical trials, most evidence arises from uncontrolled observations Interleukin 12 in Takayasu’s arteritis: Multicenter, retrospective study of 49 patients.

Sunderkotter C, Sindrilaru A. Carotid artery tenderness, claudication, ocular disturbances, central nervous system abnormalities, and weakening of pulses are the most frequent clinical features. Vaideeswar P, Deshpande JR. Phillip R, Luqmani R. Mycophenolate mofetil for the treatment of Takayasu arteritis: Pyoderma gangrenosum au cours d’une arterite de Takayasu.

Bol Med Hosp Infant Mex. Ishikawa K, Maetani S.

  FOLIA QUATERNARIA PDF

Rheumatology 44 Suppl. Participaron en el estudio 8 pacientes, 2 varones y 6 mu-jeres. Clin Radiol, 42pp. Analysis of Thirty Cases.

Takayasu Arteritis

The use of pediwtria agents in the treatment of TA has gradually become widespread during the past 15 years. Kawasaki disease, polyarteritis nodosa Rheumatic fever Systemic Lupus erythematosus Sarcoidosis Spondyloarthropathies Behcet’s disease.

Jpn J Clin Immunol. Diagnosis, treatment, and long-term management of Kawasaki disease: Constitutional symptoms are observed in a higher proportion of childhood TA as compared to adult TA.

Clasificación de las Vasculitis Sistémicas en Pediatría | Pediatría (Asunción)

Precordial pain, dyspnea, palpitations, and murmurs may reflect cardiac involvement. Acute loss of vision, sometimes associated with orbital pain, has been reported. Cutaneous manifestations of Takayasu arteritis: There are no specific laboratory abnormalities and the disease presentation is often non-specific, silent, or pauci symptomatic.

Tocilizumab for the treatment of large-vessel vasculitis giant cell arteritis, Takayasu arteritis and polymyalgia rheumatica.

Published online Sep